Audubon’s Birds of America Produced by National Museums Scotland—unfortunately, all remaining Birding on the Bay experiences ...

Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...

Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

CHICAGO, February 03, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has ...

Analyst discusses AI stock Tempus AI, highlighting potential for profitability by 2025, insider selling, and sector risks.

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the ...

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing. The ...

TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.

Former House Speaker Nancy Pelosi discloses the purchase of 50 call options in Tempus AI with a strike price of $20. Tempus AI on Tuesday announced the national launch of its AI-enabled personal ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...